FANCE expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.540000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.003600E-01
Normal-vs-Stage2
7.084400E-01
Normal-vs-Stage3
1.331610E-01
Normal-vs-Stage4
8.063000E-01
Stage1-vs-Stage2
3.845200E-01
Stage1-vs-Stage3
4.427200E-01
Stage1-vs-Stage4
3.542200E-01
Stage2-vs-Stage3
2.134400E-01
Stage2-vs-Stage4
9.071800E-01
Stage3-vs-Stage4
2.214600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.036800E-01
Normal-vs-AfricanAmerican
3.433600E-01
Normal-vs-Asian
5.985600E-01
Caucasian-vs-AfricanAmerican
5.279200E-01
Caucasian-vs-Asian
8.269200E-01
AfricanAmerican-vs-Asian
6.318000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.821400E-01
Normal-vs-Female
6.347600E-01
Male-vs-Female
7.295800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.445000E-01
Normal-vs-Age(41-60Yrs)
9.915000E-01
Normal-vs-Age(61-80Yrs)
4.112200E-01
Normal-vs-Age(81-100Yrs)
9.650800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.286400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.551000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.694800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.575650E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.440600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.039610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.383600E-01
Normal-vs-Daily Drinker
4.942800E-01
Normal-vs-Weekly Drinker
7.954400E-01
Normal-vs-Occasional Drinker
7.856600E-01
Normal-vs-Social Drinker
9.158400E-01
Non Drinker-vs-Daily Drinker
3.879600E-01
Non Drinker-vs-Weekly Drinker
9.398800E-01
Non Drinker-vs-Occasional Drinker
3.518600E-01
Non Drinker-vs-Social Drinker
9.349800E-01
Daily Drinker-vs-Weekly Drinker
4.883000E-01
Daily Drinker-vs-Occasional Drinker
7.237900E-02
Daily Drinker-vs-Social Drinker
5.328800E-01
Weekly Drinker-vs-Occasional Drinker
3.576800E-01
Weekly Drinker-vs-Social Drinker
9.043600E-01
Occasional Drinker-vs-Social Drinker
5.594400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.762000E-01
Normal-vs-Grade 2
8.781200E-01
Normal-vs-Grade 3
9.387400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.142200E-02
Grade 1-vs-Grade 3
5.663700E-03
Grade 1-vs-Grade 4
7.762000E-01
Grade 2-vs-Grade 3
1.305390E-01
Grade 2-vs-Grade 4
8.781200E-01
Grade 3-vs-Grade 4
9.387400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.534200E-01
Normal-vs-NonDiabetic
7.362200E-01
Diabetic-vs-NonDiabetic
5.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.055800E-01
Normal-vs-NoPancreatitis
6.020200E-01
Pancreatitis-vs-NoPancreatitis
2.608400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.004800E-01
Normal-vs-N1
5.726000E-01
N0-vs-N1
4.868200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.548600E-01
Normal-vs-TP53-NonMutant
7.603800E-01
TP53-Mutant-vs-TP53-NonMutant
3.785800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
